Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical total assets
Total assets on the balance sheet at the end of each period.
Acro Biomedical's total assets was $3.65K at Jun 30, 2026. For fiscal 2025 it was $14.10K, down 55.9% from the year before. The highest annual figure on record is $1.48M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.10K | -55.9% |
| FY2024 | Dec 31, 2024 | $31.97K | -45.3% |
| FY2023 | Dec 31, 2023 | $58.46K | -91.5% |
| FY2022 | Dec 31, 2022 | $687.49K | -9.7% |
| FY2021 | Dec 31, 2021 | $761.08K | -28.8% |
| FY2019 | Sep 30, 2019 | $1.07M | -27.9% |
| FY2018 | Sep 30, 2018 | $1.48M | +170.4% |
| FY2017 | Sep 30, 2017 | $548.31K | +21546.7% |
| FY2016 | Sep 30, 2016 | $2.53K | -91.4% |
| FY2015 | Sep 30, 2015 | $29.46K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $3.65K | -93.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $3.87K | -84.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $14.10K | -55.9% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $4.32K | -88.8% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $53.28K | +17.7% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $25.18K | -50.4% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $31.97K | -45.3% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $38.68K | +103.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $45.28K | -91.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $50.79K | -92.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $58.46K | -91.5% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $19.03K | -97.0% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $539.15K | -19.4% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $656.94K | -9.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $687.49K | -9.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $643.65K | +2.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $669.33K | -4.4% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $728.59K | -22.4% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $761.08K | -28.8% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $629.83K | -41.7% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $700.37K | -38.5% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $938.87K | -26.1% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $1.07M | -27.9% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $1.08M | +7.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $1.14M | +31.3% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $1.27M | +66.2% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.48M | +170.4% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $1.01M | +40304.3% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $867.92K | +43296.2% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $764.53K | +31875.5% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $548.31K | +21546.7% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $2.50K | +6.8% |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $2.00K | -83.0% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $2.39K | -91.9% |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $2.53K | – |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $2.34K | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $11.74K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | $29.46K | – |
See a number that looks wrong?